We previously identified a HSF1 small molecule inhibitor SISU-102 that inhibits the growth of both hormone sensitive and hormone-resistant PCa lines and CRPC mouse models, and this compound is now under commercial development for clinical trials14. The gene discussed is HSF1; the disease is posterior cortical atrophy.